Liquid Biopsy May Help Predict Survival in Medullary Thyroid Carcinoma
Liquid biopsy may prevent the need for unnecessary biopsies in patients with medullary thyroid carcinoma.
Liquid biopsy may prevent the need for unnecessary biopsies in patients with medullary thyroid carcinoma.
Patients with medullary thyroid cancer taking cabonzantinib lived more than 2 years longer if their tumors had a RET mutation.
Positive link to papillary, follicular, anaplastic thyroid cancer; inverse link for medullary thyroid cancer.
New sonographic patterns proposed in the provisional 2014 ATA guidelines perform well for medullary thyroid cancer.